Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 25:11:149-155.
doi: 10.1016/j.conctc.2018.07.007. eCollection 2018 Sep.

Design of an experimental protocol to examine medication non-adherence among young drivers diagnosed with ADHD: A driving simulator study

Affiliations

Design of an experimental protocol to examine medication non-adherence among young drivers diagnosed with ADHD: A driving simulator study

Yi-Ching Lee et al. Contemp Clin Trials Commun. .

Erratum in

Abstract

The diagnosis of ADHD among teens and young adults has been associated with a higher likelihood of motor vehicle crashes. Some studies suggest a beneficial effect of ADHD medication but the exact efficacy is still being debated. Further, medication adherence, which is low in this age group, can further reduce effectiveness. Our long-term objective is to reduce unsafe driving among drivers with ADHD by detecting medication non-adherence through driver behavior modeling and monitoring. As a first step, we developed the described lab study protocol to obtain reliable driver behavior data that will then be used to design and train behavior models built through machine learning. This experimental study protocol was developed to systematically compare driving behaviors under two medication conditions (before and after intake of medication) among young adults with ADHD and a control group of non-ADHD. A driving simulator was used to examine driving behaviors and interactions with traffic. The primary outcome was speed management for two comparisons (ADHD vs. non-ADHD and before vs. after medication), and secondary objectives involved understanding differences among the participants utilizing self-reported surveys about ADHD symptoms, drivers' knowledge, and perception about safety. The study protocol was designed to maximize participant safety and efficiency of data collection, as multiple measures were collected over two 2-h study visits. The sampled ADHD drivers were demographically and psychosocially similar but clinically different from the non-ADHD group. Overall, this protocol was effective in participant recruitment and retention, allowed staggered data collection, and can be incorporated in a subsequent clinical trial that examines the efficacy of a machine-learning based driver monitoring intervention.

Keywords: Attention-deficit/hyperactivity disorder (ADHD); Driving; Driving simulator; Machine learning; Medication adherence.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Steps of study procedures of regular and delayed medication conditions for ADHD participants.
Fig. 2
Fig. 2
Enrollment of ADHD participants.
Fig. 3
Fig. 3
Enrollment of non-ADHD participants.

References

    1. Jillani S.A., Kaminer Y. High risk driving in treated and untreated youth with attention deficit hyperactivity disorder: public health implications. Adolesc. Psychiatr. 2016;6(2):89–99.
    1. Barkley R.A., Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J. Saf. Res. 2007;38(1):113–128. doi: 10.1016/j.jsr.2006.09.004. - DOI - PubMed
    1. Barkley R.A., Murphy K.R., O'Connell T., Connor D.F. Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder. J. Saf. Res. 2005;36(2):121–131. doi: 10.1016/j.jsr.2005.01.001. - DOI - PubMed
    1. Barragan D., Lee Y.-C. Presented at the 6th International Conference on Driver Distraction and Inattention, Gothenburg, Sweden. 2018. Pre-crash driving behaviour of individuals with and without ADHD.
    1. Biederman J., Fried R., Hammerness P., Surman C., Mehler B., Petty C.R., Reimer B. The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm. J. Psychiatr. Res. 2012;46(4):484–491. doi: 10.1016/j.jpsychires.2012.01.007. - DOI - PubMed